MAP3K7CL antibody (AA 151-242) (FITC)
Quick Overview for MAP3K7CL antibody (AA 151-242) (FITC) (ABIN2171264)
Target
See all MAP3K7CL AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 151-242
-
Cross-Reactivity
- Rat
-
Predicted Reactivity
- Human,Cow,Sheep,Pig,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MAP3K7CL
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- MAP3K7CL (MAP3K7 C-Terminal Like (MAP3K7CL))
-
Alternative Name
- C21orf7
-
Background
-
Synonyms: Chromosome 21 open reading frame 7, Putative gene TGF beta activated kinase like, TAK1 like, TAK1 like protein, TAK1-like protein, Tak1l, TAK1L_HUMAN, TAKL.
Background: C21orf7
-
UniProt
- P57077
Target
-